Annual Cash & Cash Equivalents
N/A
December 1, 2024
Summary
- JNJ annual cash & cash equivalents is not available.
Performance
JNJ Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
N/A
December 1, 2024
Summary
- JNJ quarterly cash and cash equivalents is not available.
Performance
JNJ Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
JNJ Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
JNJ Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Johnson & Johnson Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.98 B(-19.7%) |
| Jun 2024 | - | $24.88 B(-2.3%) |
| Mar 2024 | - | $25.47 B(+16.5%) |
| Dec 2023 | $21.86 B(+69.6%) | $21.86 B(+10.8%) |
| Sep 2023 | - | $19.73 B(-6.9%) |
| Jun 2023 | - | $21.18 B(+10.5%) |
| Mar 2023 | - | $19.17 B(+48.7%) |
| Dec 2022 | $12.89 B(-11.0%) | $12.89 B(+13.5%) |
| Sep 2022 | - | $11.36 B(+3.4%) |
| Jun 2022 | - | $10.98 B(+5.0%) |
| Mar 2022 | - | $10.46 B(-27.8%) |
| Dec 2021 | $14.49 B(+3.6%) | $14.49 B(-17.7%) |
| Sep 2021 | - | $17.60 B(+22.8%) |
| Jun 2021 | - | $14.33 B(+13.1%) |
| Mar 2021 | - | $12.67 B(-9.4%) |
| Dec 2020 | $13.98 B(-19.2%) | - |
| Dec 2020 | - | $13.98 B(-26.3%) |
| Sep 2020 | - | $18.96 B(+69.7%) |
| Jun 2020 | - | $11.17 B(-28.0%) |
| Mar 2020 | - | $15.53 B(-10.3%) |
| Dec 2019 | $17.30 B(-4.4%) | $17.30 B(+6.5%) |
| Sep 2019 | - | $16.25 B(+13.0%) |
| Jun 2019 | - | $14.38 B(-2.4%) |
| Mar 2019 | - | $14.73 B(-18.6%) |
| Dec 2018 | $18.11 B(+1.6%) | $18.11 B(+12.8%) |
| Sep 2018 | - | $16.06 B(-8.6%) |
| Jun 2018 | - | $17.57 B(+20.0%) |
| Mar 2018 | - | $14.64 B(-17.9%) |
| Dec 2017 | $17.82 B(-6.1%) | $17.82 B(+13.4%) |
| Sep 2017 | - | $15.72 B(+24.8%) |
| Jun 2017 | - | $12.60 B(-39.7%) |
| Mar 2017 | - | $20.91 B(+10.2%) |
| Dec 2016 | $18.97 B(+38.2%) | $18.97 B(+4.2%) |
| Sep 2016 | - | $18.20 B(-2.3%) |
| Jun 2016 | - | $18.64 B(+34.5%) |
| Mar 2016 | - | $13.86 B(+0.9%) |
| Dec 2015 | $13.73 B(-5.4%) | $13.73 B(+0.7%) |
| Sep 2015 | - | $13.64 B(+28.2%) |
| Jun 2015 | - | $10.64 B(-11.3%) |
| Mar 2015 | - | $11.99 B(-17.5%) |
| Dec 2014 | $14.52 B(-30.6%) | $14.52 B(+5.1%) |
| Sep 2014 | - | $13.82 B(-2.9%) |
| Jun 2014 | - | $14.24 B(-27.8%) |
| Mar 2014 | - | $19.72 B(-5.8%) |
| Dec 2013 | $20.93 B(+40.3%) | $20.93 B(+21.6%) |
| Sep 2013 | - | $17.20 B(-0.6%) |
| Jun 2013 | - | $17.31 B(+16.5%) |
| Mar 2013 | - | $14.86 B(-0.4%) |
| Dec 2012 | $14.91 B(-39.2%) | $14.91 B(-3.7%) |
| Sep 2012 | - | $15.49 B(+10.3%) |
| Jun 2012 | - | $14.04 B(-53.6%) |
| Mar 2012 | - | $30.27 B(+23.3%) |
| Dec 2011 | $24.54 B(+26.8%) | $24.54 B(+57.1%) |
| Sep 2011 | - | $15.62 B(+4.3%) |
| Jun 2011 | - | $14.97 B(-33.0%) |
| Mar 2011 | - | $22.36 B(+15.5%) |
| Dec 2010 | $19.36 B(+22.4%) | $19.36 B(+35.0%) |
| Sep 2010 | - | $14.34 B(+12.8%) |
| Jun 2010 | - | $12.71 B(-7.5%) |
| Mar 2010 | - | $13.74 B(-13.1%) |
| Dec 2009 | $15.81 B(+46.8%) | $15.81 B(+33.4%) |
| Sep 2009 | - | $11.86 B(+1.5%) |
| Jun 2009 | - | $11.69 B(-7.2%) |
| Mar 2009 | - | $12.59 B(+16.9%) |
| Dec 2008 | $10.77 B(+38.6%) | $10.77 B(-23.2%) |
| Sep 2008 | - | $14.02 B(+10.8%) |
| Jun 2008 | - | $12.65 B(+20.0%) |
| Mar 2008 | - | $10.54 B(+35.6%) |
| Dec 2007 | $7.77 B(+90.3%) | $7.77 B(+17.0%) |
| Sep 2007 | - | $6.64 B(+19.2%) |
| Jun 2007 | - | $5.57 B(+7.7%) |
| Mar 2007 | - | $5.17 B(+26.7%) |
| Dec 2006 | $4.08 B | $4.08 B(-71.8%) |
| Sep 2006 | - | $14.49 B(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $14.65 B(-12.9%) |
| Mar 2006 | - | $16.82 B(+4.8%) |
| Dec 2005 | $16.05 B(+74.5%) | $16.05 B(+8.3%) |
| Sep 2005 | - | $14.82 B(+22.0%) |
| Jun 2005 | - | $12.16 B(+42.4%) |
| Mar 2005 | - | $8.54 B(-7.2%) |
| Dec 2004 | $9.20 B(+71.2%) | $9.20 B(+25.2%) |
| Sep 2004 | - | $7.35 B(+29.3%) |
| Jun 2004 | - | $5.68 B(+0.8%) |
| Mar 2004 | - | $5.64 B(+4.8%) |
| Dec 2003 | $5.38 B(+85.8%) | $5.38 B(+39.7%) |
| Sep 2003 | - | $3.85 B(+29.7%) |
| Jun 2003 | - | $2.97 B(-3.0%) |
| Mar 2003 | - | $3.06 B(+5.8%) |
| Dec 2002 | $2.89 B(-23.0%) | $2.89 B(-8.4%) |
| Sep 2002 | - | $3.16 B(+21.3%) |
| Jun 2002 | - | $2.61 B(-24.2%) |
| Mar 2002 | - | $3.44 B(-8.5%) |
| Dec 2001 | $3.76 B(-12.2%) | $3.76 B(-25.8%) |
| Sep 2001 | - | $5.07 B(+7.3%) |
| Jun 2001 | - | $4.72 B(+29.5%) |
| Mar 2001 | - | $3.65 B(-14.7%) |
| Dec 2000 | $4.28 B(+81.0%) | $4.28 B(+20.5%) |
| Sep 2000 | - | $3.55 B(+20.9%) |
| Jun 2000 | - | $2.94 B(+10.3%) |
| Mar 2000 | - | $2.66 B(+12.7%) |
| Dec 1999 | $2.36 B(+18.5%) | $2.36 B(-9.7%) |
| Sep 1999 | - | $2.62 B(+29.3%) |
| Jun 1999 | - | $2.02 B(+13.7%) |
| Mar 1999 | - | $1.78 B(-10.7%) |
| Dec 1998 | $1.99 B(-27.6%) | $1.99 B(-46.7%) |
| Sep 1998 | - | $3.74 B(+20.2%) |
| Jun 1998 | - | $3.11 B(+7.6%) |
| Mar 1998 | - | $2.89 B(+5.1%) |
| Dec 1997 | $2.75 B(+36.9%) | $2.75 B(-8.0%) |
| Sep 1997 | - | $2.99 B(+33.8%) |
| Jun 1997 | - | $2.24 B(+2.1%) |
| Mar 1997 | - | $2.19 B(+8.9%) |
| Dec 1996 | $2.01 B(+67.4%) | $2.01 B(-3.7%) |
| Sep 1996 | - | $2.09 B(+12.3%) |
| Jun 1996 | - | $1.86 B(+7.9%) |
| Mar 1996 | - | $1.72 B(+43.5%) |
| Dec 1995 | $1.20 B(+88.8%) | $1.20 B(-7.1%) |
| Sep 1995 | - | $1.29 B(+24.2%) |
| Jun 1995 | - | $1.04 B(+126.3%) |
| Mar 1995 | - | $460.00 M(-27.7%) |
| Dec 1994 | $636.00 M(+71.0%) | $636.00 M(-26.6%) |
| Sep 1994 | - | $866.00 M(+51.7%) |
| Jun 1994 | - | $571.00 M(+71.0%) |
| Mar 1994 | - | $334.00 M(-10.2%) |
| Dec 1993 | $372.00 M(-50.1%) | $372.00 M(-42.2%) |
| Sep 1993 | - | $644.00 M(+8.2%) |
| Jun 1993 | - | $595.00 M(+21.9%) |
| Mar 1993 | - | $488.00 M(-34.5%) |
| Dec 1992 | $745.00 M(+26.5%) | $745.00 M(+9.4%) |
| Sep 1992 | - | $681.00 M(+50.7%) |
| Jun 1992 | - | $452.00 M(+14.7%) |
| Mar 1992 | - | $394.00 M(-33.1%) |
| Dec 1991 | $589.00 M(-28.7%) | $589.00 M(+1.7%) |
| Sep 1991 | - | $579.00 M(+5.7%) |
| Jun 1991 | - | $548.00 M(+24.5%) |
| Mar 1991 | - | $440.00 M(-46.7%) |
| Dec 1990 | $826.00 M(+82.7%) | $826.00 M(-2.2%) |
| Sep 1990 | - | $845.00 M(+32.9%) |
| Jun 1990 | - | $636.00 M(+15.8%) |
| Mar 1990 | - | $549.00 M(+21.5%) |
| Dec 1989 | $452.00 M(-31.5%) | $452.00 M(+2.3%) |
| Sep 1989 | - | $442.00 M(+7.8%) |
| Mar 1989 | - | $410.00 M(-37.9%) |
| Dec 1988 | $660.00 M(-10.9%) | $660.00 M(-10.9%) |
| Dec 1987 | $741.00 M(-22.2%) | $741.00 M(-22.2%) |
| Dec 1986 | $952.50 M(+29.5%) | $952.50 M(+29.5%) |
| Dec 1985 | $735.60 M(+66.2%) | $735.60 M(+66.2%) |
| Dec 1984 | $442.50 M | $442.50 M |
FAQ
- What is the all time high annual cash & cash equivalents for Johnson & Johnson?
- What is the all time high quarterly cash and cash equivalents for Johnson & Johnson?
What is the all time high annual cash & cash equivalents for Johnson & Johnson?
Johnson & Johnson all-time high annual cash & cash equivalents is $24.54 B
What is the all time high quarterly cash and cash equivalents for Johnson & Johnson?
Johnson & Johnson all-time high quarterly cash and cash equivalents is $30.27 B